Brind.
  1. Zentek is continuing the commercialization of the ZenGUARD platform and developing the Albany Graphite Project, targeting Canadian purchasers under NI 45-106 rules.

Zentek's board determined on July 12, 2025, not to extend the consulting contract for the ZenGUARD production facility in Guelph.

1 report, 1 independent Updated Jul 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Zentek's board determined on July 12, 2025, not to extend the consulting contract for the ZenGUARD production facility in Guelph.

Who's involved

What this event is mainly about
ZentekGreg

How it developed

Newest first. Tap a step to see who reported it.
  1. Health Canada is considering the regulatory classification of ZenGUARD, produced at Zentek's facility in Guelph, Ontario.Sub-event
  2. Zentek's board decided not to extend the consulting contract for the ZenGUARD production facility.1 source

Keep exploring

Part of

Zentek is continuing the commercialization of the ZenGUARD platform and developing the Albany Graphite Project, targeting Canadian purchasers under NI 45-106 rules. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • ACCESS NewswireZentek Announces Management Transition GUELPH, ON / ACCESS Newswire / July 11, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development